-
GRE Composition and CREB/MITF in Melanogenesis
2026-08-31
The reference study examines glabridin, resveratrol, and ellagic acid as a combined GRE composition rather than only as isolated natural ingredients. Using melanogenesis, antioxidant, viability, and inflammatory cell assays, it identifies GRE as the strongest overall treatment and links its activity to suppression of the CREB/MITF regulatory axis.
-
LAMP1 and CXCL10-CXCR3 Control Macrophage Polarization
2026-08-31
The 2024 International Immunopharmacology study identifies LAMP1 as a context-dependent switch in CXCL10-CXCR3 regulation of macrophage polarization. By combining CXCR3 pharmacological inhibition, LAMP1 knockdown, autophagy profiling, and a poly(I:C)-induced lung injury model, the work links macrophage state to divergent inflammatory outcomes.
-
Kanamycin Sulfate in Selection and Toxin Assays
2026-08-30
Kanamycin Sulfate provides a practical, water-based selection layer for bacterial plasmid maintenance, reporter construction, and antibiotic resistance research. This guide connects that established workflow with toxin-focused anti-infection research inspired by a recent Clostridioides difficile study, while separating validated use from exploratory assay design.
-
Trolox in Oxidative Stress Assays
2026-08-29
Trolox provides a practical redox benchmark for separating broad antioxidant protection from selective lipid-peroxidation effects. This guide shows how to formulate, dose, and troubleshoot Trolox in cell assays, disease-relevant models, and high-throughput antioxidant screening.
-
(S)-(+)-Dimethindene maleate: M2 Guide
2026-08-28
This practical guide explains how (S)-(+)-Dimethindene maleate can be used as an M2 muscarinic receptor antagonist with additional H1 histamine receptor antagonism in receptor and physiology workflows. It is intended for scientific research only; the dossier does not provide potency, dosing, or directly matched paper evidence, so assay-specific validation is required.
-
SOAT1 and PHMG-Induced Pulmonary Fibrosis
2026-08-28
The reference study identifies sterol O-acyltransferase 1 (SOAT1) as a previously unrecognized driver of PHMG-induced pulmonary fibrosis by linking cholesterol ester accumulation in alveolar macrophages to defective lipophagy and fibroblast activation. Its results nominate SOAT1 inhibition, including pharmacological repurposing of avasimibe, as a preclinical strategy for reducing lipid-associated lung injury.
-
BCA Protein Quantification Kit: Practical Guide
2026-08-27
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit, SKU K4102, provides sensitive total-protein measurement for dilute samples and many detergent-containing lysates. It is intended for scientific research workflows such as protein quantification for cell lysates and sample normalization, not for diagnostic, clinical, or medical testing.
-
Trolox in Pancreatic Organoid Translation
2026-08-27
Trolox, also known as 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, can serve as more than a generic antioxidant control. This thought-leadership guide explains how to use its redox biology to strengthen pancreatic ductal organoid validation, oxidative injury research, and high-throughput antioxidant screening while keeping translational claims appropriately bounded.
-
Caspase-3/7 Inhibitor I: Applied Workflow
2026-08-26
Caspase-3/7 Inhibitor I provides a reversible, cell-permeable way to separate executioner-caspase activity from upstream stress signaling. This workflow shows how to apply it to Jurkat apoptosis assays and cautiously extend the design to Candida krusei–challenged bovine mammary epithelial cells.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-26
Saito and colleagues developed a streamlined direct 3D cluster-culture approach for generating human induced pluripotent stem cell-derived intestinal organoids with long-term propagation, differentiation, and cryopreservation capacity. The resulting organoid-derived intestinal epithelial cells contain mature enterocytes with cytochrome P450 and transporter activities, supporting more human-relevant pharmacokinetic studies than conventional animal or Caco-2 models alone.
-
Small-Molecule Pancreatic Ductal Organoid Generation
2026-08-25
Liao and colleagues describe a small-molecule culture strategy that improves the initiation and expansion of pancreatic ductal organoids while retaining ductal and acinar features. The resulting long-term, heterogeneous organoids offer a more efficient platform for studying pancreatic disease, cellular plasticity, PDAC, and drug responses.
-
5-EdU for Mechanistic Tumor Growth Research
2026-08-25
Discover how 5-Ethynyl-2'-deoxyuridine (5-EdU) can transform a cell proliferation assay from a simple endpoint into a mechanistic readout for S phase DNA synthesis detection and pancreatic tumor growth research.
-
GRE Combination Suppresses Melanogenesis via CREB/MITF
2026-08-24
The reference study evaluates glabridin, resveratrol, and ellagic acid as a combined GRE composition rather than as isolated anti-melanogenic agents. In B16F10 and RAW264.7 cell models, GRE produced the strongest overall profile among the tested conditions by reducing melanin production, tyrosinase activity, CREB phosphorylation, MITF-associated signaling, nitric oxide output, and chemical oxidative activity.
-
Tranexamic Acid in Fibrinolysis Research
2026-08-24
Translate Tranexamic Acid’s antifibrinolytic mechanism into reproducible clot-stability, platelet-adhesion, and neutrophil-interaction workflows. The approach also shows how a small-molecule inhibitor can support biomaterial screening for hemostatic dressings while keeping assay interpretation separate from clinical claims.
-
a-MSH, amide in Pigmentation Research
2026-08-23
Use a-MSH, amide as a defined melanocortin stimulus for reproducible melanin synthesis modulation, receptor pharmacology, and inflammation workflows. Its value is greatest when paired with viability, tyrosinase, MITF, and inflammatory readouts rather than treated as a single-endpoint pigmentation reagent.